Expertise in
9
conditions

Alexis F. Turgeon

Quebec, QC, CA 
Expertise in
9
conditions
Quebec, QC, CA 

Overview

Alexis Turgeon practices practicing medicine in Quebec, Canada.

Ms. Turgeon is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Traumatic Brain Injury, Subarachnoid Hemorrhage, Severe Acute Respiratory Syndrome (SARS), Hepatectomy, and Cystectomy.

She is actively involved in clinical research, co-authoring 342 peer reviewed articles and participating in 6 clinical trials.

Gender

Female

Locations

Quebec, QC, Canada
Other Locations
Canada
Laval, QC, Canada
St. Michael's Hospital, Unity Health Toronto St. Michael's Hospital, Ottawa, ON, Canada
St. Joseph's Healthcare Hamilton, Ottawa, the Massawippi Valley Foundation, Ayer's Cliff, CHU Dr. Georges L. Dumont, Island Health Authority, Halton Healthcare
Oakville, ON, Canada
Montreal, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

VItamin C in Thermal injuRY: The VICToRY Trial A Phase III Multi-center Randomized Trial
VItamin C in Thermal injuRY: The VICToRY Trial A Phase III Multi-center Randomized Trial
Enrollment Status: Suspended
Publish Date: April 06, 2026
Intervention Type: Drug
Study Phase: Phase 3
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2025
Intervention Type: Drug
Study Phase: Phase 2
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
Enrollment Status: Unknown
Publish Date: October 13, 2023
Intervention Type: Drug
Study Drugs: IFN-Beta1a, Remdesivir
Study Phase: Phase 3
Heparin AnticoaguLation to Improve Outcomes in Septic Shock: The HALO International Phase II RCT
Heparin AnticoaguLation to Improve Outcomes in Septic Shock: The HALO International Phase II RCT
Enrollment Status: Terminated
Publish Date: May 24, 2022
Intervention Type: Other, Drug
Study Drug: Unfractionated heparin
Study Phase: Phase 2
Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Enrollment Status: Unknown
Publish Date: December 30, 2021
Intervention Type: Dietary supplement
Study Phase: Phase 3
View 5 Less Clinical Trials

341 Total Publications

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Journal: Anesthesiology
Published: September 08, 2026

Frequently Asked Questions about Alexis F. Turgeon

Is Alexis F. Turgeon a top-rated expert for Traumatic Brain Injury?

MediFind is an objective health platform that identifies experts based on real-world data. Alexis F. Turgeon is classified as an Distinguished expert for Traumatic Brain Injury, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alexis F. Turgeon participate in research or clinical trials?

Yes. Alexis F. Turgeon has published 341 articles and abstracts on conditions like Traumatic Brain Injury. You can view a list of Alexis F. Turgeon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Turgeon's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile